Marina Trilesskaya, M.D. is an interventional cardiology internal medicine in Oakland, CA with 18 years of experience. The provider is an area of medicine within the subspecialty of cardiology, which uses specialized imaging and other diagnostic techniques to evaluate blood flow and pressure in the coronary arteries and chambers of the heart and uses technical procedures and medications to treat abnormalities that impair the function of the cardiovascular system. Marina Trilesskaya, M.D. NPI is 1588893580. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a female.
Education
Medical School: UNIVERSITY OF CALIFORNIA, DAVIS SCHOOL OF MEDICINE
Graduation Year:2006
The provider's business location address is:
1411 E 31ST ST
OAKLAND, CA
ZIP 94602-018
Phone: (105) 437-4414
The NPI 1588893580 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report (HCPCS:93010)
- Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function (HCPCS:93306)
- Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 15 minutes (HCPCS:99152)
- Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report (HCPCS:93018)
- Insertion of catheter in left heart for imaging of blood vessels or grafts and left lower heart (HCPCS:93458)
The enumeration date for this NPI number is 7/11/2009 and was last updated on 5/22/2023.